CURRENT ISSUE Current Issue Cover
VOL 10 NO 7 • SEP/OCT 2019
 
Section Seperator

TODAY'S NEWS

FDA Pipeline: Priority Reviews in Prosta...

This week, the U.S. Food and Drug Administration (...

Genomic Landscape of Merkel Cell Carcino...

Researchers have developed the largest descriptive...

Addition of Pemetrexed/Carboplatin to Ge...

In a single-center phase III trial reported in the...

Swallowing-Related Quality of Life After...

In the phase II ORATOR trial reported in The Lance...

Impact of Genes on Total Number and Type...

A study by Duffy et al in the Journal of Investiga...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Oncology Couples’ Retreats: Relationships

A cancer diagnosis not only affects multiple aspects of a patient’s life, but can also have a significant impact on...

A Review of PI3K Inhibitors in B-Cell Malignancies

The phosphoinositide 3-kinase (PI3K) pathway plays a primary role in cellular proliferation and metabolism...

Letermovir for Cytomegalovirus Prevention

Cytomegalovirus (CMV) is a double-stranded DNA virus that infects (seropositive on screening) more than half of adults...

What Caused This Left Renal Infiltrate?

VD is a 44-year-old female who presented on July 10, 2018, to the Urology clinic with a left renal pelvis lesion....

Implementation of a Survivorship Care Plan

There is conflicting evidence from the small number of randomized controlled trials that have assessed the benefit...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights More Highlights
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.